3 Recession-Proof Stocks With Nice Dividends

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

Should you invest $1,000 in Kimberly-Clark right now?

Before you consider Kimberly-Clark, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kimberly-Clark wasn't on the list.

While Kimberly-Clark currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Kimberly-Clark (KMB)
4.6127 of 5 stars
$136.48+0.0%3.58%25.09Hold$135.21
Johnson & Johnson (JNJ)
4.9338 of 5 stars
$146.71-0.1%3.24%9.15Hold$175.86
Coca-Cola (KO)
4.0856 of 5 stars
$61.86+0.2%3.14%24.94Moderate Buy$67.22
PepsiCo (PEP)
4.3599 of 5 stars
$177.97+0.7%2.84%26.76Moderate Buy$187.42
Procter & Gamble (PG)
4.546 of 5 stars
$162.46-0.1%2.48%26.55Moderate Buy$169.76
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Johnson & Johnson's Dip is a Strategic Buy Point for Investors

Johnson & Johnson's Dip is a Strategic Buy Point for Investors

JNJ shares hit a low, trading near $145 at under 14X earnings. With a high dividend yield, it's poised for a rebound.

Search Headlines: